Dev48
Language
  • About
  • Services
  • Industries
  • Technologies
  • Articles
  • Contacts
Book a call
    Home/Articles/Francis van parys outlines our priorities for customers in oxford nanopores next
Dev48
info@dev48.org+375 29 320-40-96WhatsApp@isky_by

© 2026 · All rights reserved.

Francis Van Parys outlines our priorities for customers in Oxford Nanopore's next phase of growth

Фото: faustomanasse (Pixabay) — https://pixabay.com/photos/umbria-assisi-basilica-st-francis-3662403/

Source: Oxford Nanopore•September 26, 2026 at 04:43 AM

Francis Van Parys outlines our priorities for customers in Oxford Nanopore's next phase of growth

As Oxford Nanopore announces its H1 2026 results, CEO Francis Van Parys has shared a new video message with customers, partners and the wider nanopore community, setting out his priorities for the company's next chapter.

Six months into the role, Francis reflects on what he has learned from conversations with customers around the world and how that feedback is shaping Oxford Nanopore's focus for the years ahead.

At the heart of his message is the goal of helping more customers unlock the full potential of nanopore technology in routine use.

While Oxford Nanopore's platform continues to drive breakthroughs across research, biopharma and clinical, Francis explains how the company is working to make its solutions easier to adopt, integrate and scale. Francis also reaffirms the company's commitment to the research community, whose work continues to expand the possibilities of Oxford Nanopore sequencing.

Looking ahead, he discusses ongoing investment in the technologies, software, expertise and support that help customers generate value from nanopore data, as well as the role customers and partners will play in shaping the future of the platform.

Watch the video below to hear Francis's reflections on his first six months as CEO and his vision for the next phase of Oxford Nanopore's journey.

← All articles

What this article says

More in HealthTech & MedTech

All →
The Future of Radiotherapy is Here: Siemens Healthineers Launches Accela
Varian

The Future of Radiotherapy is Here: Siemens Healthineers Launches Accela

What to Do if You’re Going Through Diabetes Burnout
Dexcom

What to Do if You’re Going Through Diabetes Burnout

New Dexcom G7 15 Day CGM: Easy to use, Longer Wear Time, More Accurate
Dexcom

New Dexcom G7 15 Day CGM: Easy to use, Longer Wear Time, More Accurate

Time in Range for Diabetes Management with CGM
Dexcom

Time in Range for Diabetes Management with CGM

Levine Heart and Wellness Delivers Proactive Care
Athenahealth

Levine Heart and Wellness Delivers Proactive Care

Bourne Family Medicine Maximizes Revenue
Athenahealth

Bourne Family Medicine Maximizes Revenue

More from Oxford Nanopore

mSCAPE: a national collaboration using metagenomics to protect public health
Oxford Nanopore

mSCAPE: a national collaboration using metagenomics to protect public health

Science Unlocked: publication picks from September 2026
Oxford Nanopore

Science Unlocked: publication picks from September 2026

Appointment of Chief Business Development Officer
Oxford Nanopore

Appointment of Chief Business Development Officer

RAPID answers for rare diseases
Oxford Nanopore

RAPID answers for rare diseases

Healthcare leaders expect genomics to become part of routine care within a decade
Oxford Nanopore

Healthcare leaders expect genomics to become part of routine care within a decade

Oxford Nanopore joins global rare disease network RISE to expand access to genomic testing
Oxford Nanopore

Oxford Nanopore joins global rare disease network RISE to expand access to genomic testing